Thus, identification of the BRCA2 gene in a patient would be a reason to screen for an associated pancreatic cancer, especially in the Ashkenazi Jewish population who have a high rate of BRCA2 mutations [34]. Here, BRCA2 is linked to pancreatic neoplasm.